One surgery, two problems: new device takes on glaucoma and cataracts together

NCT ID NCT06948773

Ongoing Disease control Sponsor: Sight Sciences, Inc. Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests a new device called the Helix Surgical System in people who have both primary open-angle glaucoma and cataracts. The device is used during cataract surgery to open up the eye's natural drainage channels, which may help lower eye pressure. The goal is to see if the device is safe and can reduce the need for glaucoma medications. The study involves 25 adults aged 45 and older with mild to moderate glaucoma.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Helix Surgical System (a handheld device that opens drainage channels in the eye)
What this could lead to: If successful, this device could offer a single-surgery option to treat both glaucoma and cataracts, potentially reducing the need for daily eye drops.
What could go wrong: This is a small, early pilot study with only 25 participants, so results may not apply to everyone. The device is new, and long-term safety and effectiveness are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT PRIMARY OPEN ANGLE GLAUCOMA

Contacts and locations

Show contact details

Locations

Panama Eye Center

Panama City, Panama

More trials for these conditions

Other studies related to the condition(s) this trial covers.